BACKGROUND AND STUDY AIMS: Saline as an injection solution for endoscopic resection techniques has several disadvantages such as a short-lasting effect leading to a potentially higher risk of bleeding and perforation. The new substance of photocrosslinkable chitosan hydrogel in a DMEM/F12 medium (PCH) can be converted into an insoluble hydrogel by ultraviolet irradiation for 30 s, and was evaluated in two sets of animal experiments. METHODS: 18 pigs were used in the two parts of the study. First, mucosal resections were done with either PCH or hypertonic saline; the effects of both agents on wound healing were examined endoscopically and histologically. Second, in vivo degradation of PCH was examined using six pig stomachs. RESULT: PCH injection led to a longer-lasting elevation with clearer margins, compared with hypertonic saline, thus enabling precise endoscopic submucosal dissection (ESD) along the margins of the elevated mucosa. The endoscopic appearance after ESD was similar in both groups. PCH biodegradation was completed within 8 weeks according to endoscopic and histologic analyses. CONCLUSION: PCH is a promising agent for submucosal injection prior to various techniques of endoresection. It should be evaluated in clinical trials after biocompatibility testing for PCH is completed.
BACKGROUND AND STUDY AIMS: Saline as an injection solution for endoscopic resection techniques has several disadvantages such as a short-lasting effect leading to a potentially higher risk of bleeding and perforation. The new substance of photocrosslinkable chitosan hydrogel in a DMEM/F12 medium (PCH) can be converted into an insoluble hydrogel by ultraviolet irradiation for 30 s, and was evaluated in two sets of animal experiments. METHODS: 18 pigs were used in the two parts of the study. First, mucosal resections were done with either PCH or hypertonic saline; the effects of both agents on wound healing were examined endoscopically and histologically. Second, in vivo degradation of PCH was examined using six pig stomachs. RESULT: PCH injection led to a longer-lasting elevation with clearer margins, compared with hypertonic saline, thus enabling precise endoscopic submucosal dissection (ESD) along the margins of the elevated mucosa. The endoscopic appearance after ESD was similar in both groups. PCH biodegradation was completed within 8 weeks according to endoscopic and histologic analyses. CONCLUSION:PCH is a promising agent for submucosal injection prior to various techniques of endoresection. It should be evaluated in clinical trials after biocompatibility testing for PCH is completed.
Authors: Jin Hee Maeng; Byoung Wook Bang; Eunhye Lee; Jungju Kim; Hyung Gil Kim; Don Haeng Lee; Su-Geun Yang Journal: J Mater Sci Mater Med Date: 2013-12-14 Impact factor: 3.896
Authors: Han Jo Jeon; Hyuk Soon Choi; Eun Ju Bang; Kang Won Lee; Sang Hyun Kim; Jae Min Lee; Eun Sun Kim; Bora Keum; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Seung Jeong; Jong Hyuk Kim Journal: PLoS One Date: 2021-12-09 Impact factor: 3.240
Authors: Han Jo Jeon; Seung Jeong; Hyuk Soon Choi; Se Hyun Jang; Sang Hoon Kim; Seung Han Kim; Jae Min Lee; Eun Sun Kim; Bora Keum; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Jong Hoon Chung; Seong Nam Kim Journal: Gut Liver Date: 2021-03-15 Impact factor: 4.519